TNKS and cancer: These findings reveal a role for tankyrases in the regulation of LKB1 and provide a strong rationale for clinical application of tankyrase inhibitors for cancer treatment in LKB1 wild-type tumors and glycemic control of diabetic patients (Supplementary Fig. 7).